Nexpowder
Payments companies reported to CMS as associated with Nexpowder. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nexpowder, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nexpowder
These are the largest totals companies reported as associated with Nexpowder. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Amit Bhatt | Cleveland, OH | Gastroenterology (Internal Medicine) | $2,645.79 |
| Uzma Siddiqui | Chicago, IL | Gastroenterology (Internal Medicine) | $1,650.00 |
| John Vargo | Independence, OH | Gastroenterology (Internal Medicine) | $692.53 |
| Neal Mehta | Chicago, IL | Gastroenterology (Internal Medicine) | $675.00 |
| Dennis Yang | Orlando, FL | Gastroenterology (Internal Medicine) | $662.73 |
| Carlos Simons Linares | Maywood, IL | Gastroenterology (Internal Medicine) | $567.96 |
| Peter Draganov | Gainesville, FL | Gastroenterology (Internal Medicine) | $556.95 |
| Vivek Kaul | Rochester, NY | Gastroenterology (Internal Medicine) | $353.46 |
| Nirav Thosani | Houston, TX | Gastroenterology (Internal Medicine) | $348.86 |
| Joo Hwang | Stanford, CA | Gastroenterology (Internal Medicine) | $339.49 |
Prescribed Nexpowder?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.